498 related articles for article (PubMed ID: 36285980)
1. Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.
Piotrowski WJ; Martusewicz-Boros MM; Białas AJ; Barczyk A; Batko B; Błasińska K; Boros PW; Górska K; Grzanka P; Jassem E; Jastrzębski D; Kaczyńska J; Kowal-Bielecka O; Kucharz E; Kuś J; Kuźnar-Kamińska B; Kwiatkowska B; Langfort R; Lewandowska K; Mackiewicz B; Majewski S; Makowska J; Miłkowska-Dymanowska J; Puścińska E; Siemińska A; Sobiecka M; Soroka-Dąda RA; Szołkowska M; Wiatr E; Ziora D; Śliwiński P
Adv Respir Med; 2022 Oct; 90(5):425-450. PubMed ID: 36285980
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Hambly N; Farooqi MM; Dvorkin-Gheva A; Donohoe K; Garlick K; Scallan C; Chong SG; MacIsaac S; Assayag D; Johannson KA; Fell CD; Marcoux V; Manganas H; Morisset J; Comes A; Fisher JH; Shapera S; Gershon AS; To T; Wong AW; Sadatsafavi M; Wilcox PG; Halayko AJ; Khalil N; Cox G; Richeldi L; Ryerson CJ; Kolb M
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35273032
[TBL] [Abstract][Full Text] [Related]
3. Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study.
Joung KI; Park H; Park S; Shin JY; Kim YH
BMC Pulm Med; 2023 Mar; 23(1):98. PubMed ID: 36949407
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
5. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
[No Abstract] [Full Text] [Related]
6. Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.
Strykowski R; Adegunsoye A
Immunol Allergy Clin North Am; 2023 May; 43(2):209-228. PubMed ID: 37055085
[TBL] [Abstract][Full Text] [Related]
7. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
[TBL] [Abstract][Full Text] [Related]
8. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases.
Wollin L; Distler JHW; Redente EF; Riches DWH; Stowasser S; Schlenker-Herceg R; Maher TM; Kolb M
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31285305
[TBL] [Abstract][Full Text] [Related]
9. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
10. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
11. Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies.
Li DY; Liu X; Huang JY; Hang WL; Yu GR; Xu Y
Ther Adv Respir Dis; 2024; 18():17534666241232561. PubMed ID: 38414439
[TBL] [Abstract][Full Text] [Related]
12. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
Pugashetti JV; Adegunsoye A; Wu Z; Lee CT; Srikrishnan A; Ghodrati S; Vo V; Renzoni EA; Wells AU; Garcia CK; Chua F; Newton CA; Molyneaux PL; Oldham JM
Am J Respir Crit Care Med; 2023 Jan; 207(1):69-76. PubMed ID: 35943866
[No Abstract] [Full Text] [Related]
13. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V
Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965
[No Abstract] [Full Text] [Related]
14. Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease.
Hoffmann-Vold AM; Weigt SS; Saggar R; Palchevskiy V; Volkmann ER; Liang LL; Ross D; Ardehali A; Lynch JP; Belperio JA
EBioMedicine; 2019 Dec; 50():379-386. PubMed ID: 31732480
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Therapeutic Developments in Progressive Pulmonary Fibrosis.
Molina-Molina M; Buendia-Roldan I; Castillo D; Caro F; Valenzuela C; Selman M
Arch Bronconeumol; 2022 May; 58(5):418-424. PubMed ID: 35312511
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Raghu G; Remy-Jardin M; Richeldi L; Thomson CC; Inoue Y; Johkoh T; Kreuter M; Lynch DA; Maher TM; Martinez FJ; Molina-Molina M; Myers JL; Nicholson AG; Ryerson CJ; Strek ME; Troy LK; Wijsenbeek M; Mammen MJ; Hossain T; Bissell BD; Herman DD; Hon SM; Kheir F; Khor YH; Macrea M; Antoniou KM; Bouros D; Buendia-Roldan I; Caro F; Crestani B; Ho L; Morisset J; Olson AL; Podolanczuk A; Poletti V; Selman M; Ewing T; Jones S; Knight SL; Ghazipura M; Wilson KC
Am J Respir Crit Care Med; 2022 May; 205(9):e18-e47. PubMed ID: 35486072
[No Abstract] [Full Text] [Related]
17. Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease.
Gibson CD; Kugler MC; Deshwal H; Munger JS; Condos R
Lung; 2020 Aug; 198(4):597-608. PubMed ID: 32591895
[TBL] [Abstract][Full Text] [Related]
18. Progression of fibrosing interstitial lung disease.
Wong AW; Ryerson CJ; Guler SA
Respir Res; 2020 Jan; 21(1):32. PubMed ID: 31996266
[TBL] [Abstract][Full Text] [Related]
19. Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis.
Piotrowski WJ; Bestry I; Białas AJ; Boros PW; Grzanka P; Jassem E; Jastrzębski D; Klimczak D; Langfort R; Lewandowska K; Majewski S; Martusewicz-Boros MM; Onisch K; Puścińska E; Siemińska A; Sobiecka M; Szołkowska M; Wiatr E; Wilczyński G; Ziora D; Kuś J
Adv Respir Med; 2020; 88(1):41-93. PubMed ID: 32153010
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and real-life experience in progressive pulmonary fibrosis.
Valenzuela C; Cottin V
Curr Opin Pulm Med; 2022 Sep; 28(5):407-413. PubMed ID: 35938201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
